Published in Surgery Litigation and Law Weekly, May 19th, 2006
Raloxifene (Evista) is currently prescribed for osteoporosis.
"These results indicate an important and significant breakthrough in our ongoing battle with breast cancer, and serve as an example of the value of clinical trials in breast cancer research and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly